TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Indonesia delays rollout of AstraZeneca vaccine

The Jakarta Post Image
A vendor shows his COVID-19 vaccination card after being inoculated at Melong Market in Cimahi, West Java, on Feb. 24. Market vendors are high up in the government’s vaccination drive, because their work exposes them to a relatively high risk of coronavirus transmission.(Antara/Raisan Al Farisi)
Marchio Irfan Gorbiano
PREMIUM
Jakarta   ●   Tue, March 16, 2021

Indonesia is delaying the rollout of a COVID-19 vaccine manufactured by British-Swedish pharmaceutical company AstraZeneca pending a review by the World Health Organization (WHO) into concerns about blood clots, a move that experts say could affect its ambitious vaccination targets.

The Food and Drug Monitoring Agency (BPOM) is liaising with the WHO and the Strategic Advisory Group of Experts on Immunization (SAGE) to decide whether to use the AstraZeneca vaccine in the government’s mass vaccination program.

“Hopefully, [we will have clarity] soon, because the vaccines [we have already received] have an expiration date of late May,” Health Minister Budi Gunadi Sadikin told lawmakers at a hearing on Monday.

Indonesia joins Denmark, Norway, Ireland, the Netherlands and other countries that have also suspended usage of the AstraZeneca jab i...

to Read Full Story

SUBSCRIBE NOW

Starting from IDR 55,000/month

  • Unlimited access to our content on web and app
  • No advertising, no interruption
  • A bonus subscription to share
  • Bookmark and night mode functions on app
  • Subscription to our newsletters

We accept